Skip to Main Content

In the above video, Stephen M. Hahn, MD, Commissioner of Food and Drugs, U.S. Food and Drug Administration has an in-depth one-on-one conversation with Cartier Esham, PhD, Executive Vice President, Emerging Companies, Biotechnology Innovation Organization about the Covid-19 Pandemic and what it means for the FDA.